Scalability
High affordability
Proprietary technology
Agile team
What We Offer
Our proprietary technology is based on the efficient use of novel, GMO-free biocatalytic cascades. We have designed and engineered these pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce human milk oligosaccharides and tailor the glycosylation of therapeutic proteins.
Nucleotide Sugars
For applications in R&D, nutrition and pharma. Produced in large scales, available at affordable costs.
Human Milk Oligosaccharides (HMO)
Novel complex human milk oligosaccharides (HMOs) for applications in infant nutrition.
In Vitro Glycoengineering
(IVGE)
Gain full control over glycosylation with our in-vitro glycosylation toolbox. Scalable to biopharmaceutical production scales.
Our Partners
